In Today’s Medical Developments, Cleerly founder and CEO Dr. James K. Min explains why the current approach to cardiovascular care is flawed — and prevents personalized care. Cleerly’s AI-enabled technology solves many of these problems with its precise, whole-heart phenotyping. Read the full article